Sinovation Ventures

VIZZIO Technologies Welcomes Renowned AI expert Dr Lee Kai Fu to its Board of Directors and Chau Nguyen as Co-CEO at GITEX 2023

Retrieved on: 
Tuesday, October 17, 2023
Google China, Engineering, Digital twin, ESG, Intelligence, Government, GITEX, Western world, Built environment, McKinsey & Company, Artificial intelligence, Growth, Architecture, Sinovation Ventures, City, Satellite imagery, Research, Video game, 3D printing, AI, Western Market

Dr Lee Kai-Fu, a renowned AI expert, now sits on the Board of Directors, while Chau Nguyen, ex-Partner at McKinsey & Company, is the new co-CEO, serving alongside Dr Jon Lee, who remains VIZZIO's Founder and CEO.

Key Points: 
  • Dr Lee Kai-Fu, a renowned AI expert, now sits on the Board of Directors, while Chau Nguyen, ex-Partner at McKinsey & Company, is the new co-CEO, serving alongside Dr Jon Lee, who remains VIZZIO's Founder and CEO.
  • VIZZIO will exhibit at GITEX 2023, featuring its digital replica of Planet Earth, including a 3D digital twin model of Middle East cities, at booth number 9-B20.
  • His appointment is a testament to VIZZIO's global relevance and the trust it commands in the international AI community.
  • Mr Nguyen, alongside Dr Jon Lee, will be at GITEX 2023, showcasing the company's digital replica of Planet Earth, which includes a 3D digital twin model of Middle East cities.

All-in-One collaboration tool AFFiNE, fastest growth ever in GitHub history, raises $8M funding round

Retrieved on: 
Monday, October 16, 2023
Redpoint Ventures, Software as a service, Database, Sinovation Ventures, GitHub, Star, Film industry, Series, Affine

The company said today it has raised $8 million in Series Pre-A funding bringing its total value to nearly $40 million.

Key Points: 
  • The company said today it has raised $8 million in Series Pre-A funding bringing its total value to nearly $40 million.
  • With its powerful features, AFFiNE confidently promises to revolutionize the way users write, plan, and present their ideas, eliminating the need for toggling between different collaboration tools.
  • Within 43 days since its first launch, AFFiNE has achieved a staggering 10,000 GitHub Stars, setting a new record for the fastest growth ever achieved on the platform.
  • Recently, AFFiNE announced its new financing plan in a Series A round for product development and commercial operations.

Fortune Selects Abu Dhabi as Host City of the 2023 Fortune Global Forum

Retrieved on: 
Tuesday, January 24, 2023
Fortune Global Forum, Emirates Palace, Economy, The Walt Disney Company, Toronto Global Forum, MENA, Johnson & Johnson, Food security, Abu Dhabi Department of Culture and Tourism, Partnership, IBM, J. P. Morgan, Climate change, Growth, ESG, AB InBev, Tencent, Economic development, Sinovation Ventures, Business, JPMorgan Chase, Cryptocurrency, Tourism, Apple, Ali Baba (disambiguation), FedEx

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Fortune has announced that the 2023 Fortune Global Forum, the preeminent gathering for the CEOs of the world's largest multinational companies, will take place in Abu Dhabi, UAE, from November 27-29. The announcement was made by Fortune CEO Alan Murray and His Excellency Rashed Al Blooshi, Undersecretary of the Abu Dhabi Department of Economic Development at a joint press conference on the morning of January 24 at Emirates Palace in Abu Dhabi.

Key Points: 
  • NEW YORK, Jan. 24, 2023 /PRNewswire/ -- Fortune has announced that the 2023 Fortune Global Forum , the preeminent gathering for the CEOs of the world's largest multinational companies, will take place in Abu Dhabi, UAE, from November 27-29.
  • Fortune announces the 2023 Fortune Global Forum will take place in Abu Dhabi, UAE, on November 27-29.
  • This will be the first time the Fortune Global Forum will be hosted in the Middle East/North Africa (MENA) region.
  • The Fortune Global Forum convenes heads of state and economic leaders with the CEOs of the world's biggest multinational companies.

Amberstone Biosciences Secures $12 Million Series A Financing to Advance Immuno-Oncology Pipeline of Tumor Microenvironment Activated Therapeutics

Retrieved on: 
Monday, January 3, 2022
Oncology, Health, General Health, Research, Science, Biotechnology, Dai, Tumor microenvironment, Monoclonal antibody, Health, Engineering, Cancer, Doctor of Philosophy, TMT, City, MD–PhD, Seth Sinovic, Venture, NASDAQ, RMB, Electronics, CEO, Equity, IND, Artificial intelligence, Patient, Australian Artificial Intelligence Institute, Intelligence, Biology, VC, Pharmaceutical industry, Amber, Thrive, Amberstone Biosciences, Inc., Viva BioInnovator, Co-win Ventures, Sinovation Ventures, AMBERSTONE BIOSCIENCES, INC., VIVA BIOINNOVATOR, CO-WIN VENTURES, SINOVATION VENTURES

Amberstone Biosciences ( www.amberstonebio.com ), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing round.

Key Points: 
  • Amberstone Biosciences ( www.amberstonebio.com ), an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, today announced the completion of a $12 million Series A financing round.
  • Amberstone will use the proceeds from the financing to advance its highly differentiated tumor microenvironment activated therapeutic programs including bispecific antibodies and immunocytokines to the investigational new drug application (IND) enabling stage.
  • We are tremendously grateful for the strong support from our new and existing investors, said Amberstone Biosciences President and CEO, George Wu, PhD.
  • With our unique Tumor Microenvironment Activated Therapeutics (T-MATE) programs, we aim to develop safer and more effective therapies to benefit cancer patients.